Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Francesca Cefaloni
Observed names:
F Cefaloni,
F. Cefaloni
Institutions:
Università Cattolica del Sacro Cuore,
King's College London
Observed institutions:
Università Cattolica del Sacro Cuore,
King's College London,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0009-0004-6929-0912
Observed ORCID:
0009-0004-6929-0912
OpenAlex ID:
A5038995288
Clinical and Biological Remission With Tezepelumab: The Real‐World Response in Severe Uncontrolled Asthma
2025
·
Jessica Gates
, Faizan Haris
, et al.
·
Allergy
·
57
PDF
Sinonasal Outcomes Obtained after 2 Years of Treatment with Benralizumab in Patients with Severe Eosinophilic Asthma and CRSwNP: A “Real-Life” Observational Study
2024
·
Eugenio De Corso
, Dario Antonio Mele
, et al.
·
Journal of Personalized Medicine
·
13
PDF
The Impact of Telemedicine during Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic and Future Perspectives: A Systematic Review
2023
·
Giorgio Monteleone
, Giovanni Terzulli
, et al.
·
Respiration
·
12
A survey study on antibiotic prescription practices for acute asthma exacerbations: An European academy of allergy and clinical immunology task force report
2024
·
Anne‐Lotte Redel
, Wojciech Feleszko
, et al.
·
Clinical and Translational Allergy
·
8
PDF
When hypereosinophilia occurs during dupilumab therapy: evidence-based strategies for clinical management in respiratory indications
2025
·
Marco Caminati
, Andrea Portacci
, et al.
·
Expert Review of Respiratory Medicine
·
5
Perception of the role of Telemedicine in Interstitial Lung Diseases: Findings from Società Italiana di Pneumologia/ Italian Respiratory Society (SIP-IRS) survey
2025
·
Giorgio Monteleone
, Gioele Castelli
, et al.
·
Multidisciplinary Respiratory Medicine
·
4
PDF
Antibiotics for Acute Wheezing and Asthma Exacerbations: An EAACI Position Paper and Systematic Review
2025
·
Anne‐Lotte Redel
, Wojciech Feleszko
, et al.
·
Allergy
·
3
Profile of mild/moderate asthma patients: Baseline data from the MANI cohort
2025
·
Giovanna Elisiana Carpagnano
, Matteo Bonini
, et al.
·
World Allergy Organization Journal
·
3
PDF
Small Airways Disease as a Novel Target for Mepolizumab in Asthma—The SASAM Prospective Real-Life Study
2025
·
Matteo Bonini
, Cristina Boccabella
, et al.
·
Journal of Clinical Medicine
·
3
PDF
Upper and lower airway crosstalk in acute exacerbations of COPD: a clinical and biological overview
2026
·
Simone Ielo
, Lorenzo Carriera
, et al.
·
Expert Review of Respiratory Medicine
·
2
PDF
Fractional exhaled nitric oxide as a novel biomarker of relapse in eosinophilic granulomatosis with polyangiitis
2026
·
Francesca Cefaloni
, Anne-Catherine Maynard-Paquette
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
2
Smart Devices and Digital Therapeutics for Asthma Care: Regulatory Challenges
2025
·
Francesca Cefaloni
, Luca Passantino
, et al.
·
Health informatics
·
2
Mepolizumab improves small airway disease in severe eosinophilic asthmatics
2023
·
Francesca Cefaloni
, Cristina Boccabella
, et al.
·
European Respiratory Journal
·
2
Characterizing exacerbations in severe asthma patients treated with tezepelumab
2025
·
Faizan Haris
, Raphael Birch
, et al.
·
European Respiratory Journal
·
1
Fraction Exhaled Nitric Oxide as a Novel Biomarker of Relapse in Eosinophilic Granulomatosis With Polyangiitis
2025
·
F. Cefaloni
, A.-C. Maynard-Paquette
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
1
Anti-inflammatory effects of inhaled corticosteroids-containing treatment for symptom relief: a randomized crossover trial in asthma
2026
·
Federico Baraldi
, Francesca Cefaloni
, et al.
·
European Respiratory Journal
Asthma and Sinonasal Diseases: Shared Clinical Comorbidities, Inflammatory Pathways and Management Strategies
2026
·
Francesca Cefaloni
, Enrico Schiavi
, et al.
·
Medical Sciences
Corrigendum to “Adherence to inhaled treatment is associated with better disease control and quality of life in mild-to-moderate asthma” [Respir. Med. 262, (2026), 109127]
2026
·
Nicola Scichilone
, Giulia Genduso
, et al.
·
Respiratory Medicine
PDF
Late Breaking Abstract - Investigating the inflammatory profile of exacerbations in patients with severe asthma receiving tezepelumab: the phase IV TezEx study
2026
·
Faizan Haris
, Francesca Cefaloni
, et al.
·
European Respiratory Journal
Variability of Impulse Oscillometry parameters as Predictor of Severe Asthma Remission
2026
·
Mario Di Stasio
, Francesca Cefaloni
, et al.
·
European Respiratory Journal
Adherence to inhaled treatment is associated with better disease control and quality of life in mild-to-moderate asthma
2026
·
Nicola Scichilone
, Giulia Genduso
, et al.
·
Respiratory Medicine
B29-21 Do Not Be Sad: Complete Remission Can Be Achieved
2026
·
F Cefaloni
, E Schiavi
, et al.
·
American Journal of Respiratory and Critical Care Medicine
A32-04 Inflammatory and Lung Function Changes at the Onset of Asthma Symptoms by Anti Inflammatory Reliever Therapy: The Civetta Study
2026
·
F Baraldi
, F Alfano
, et al.
·
American Journal of Respiratory and Critical Care Medicine
ERS Congress 2025: highlights from the Airway Diseases Assembly
2026
·
Francesca Cefaloni
, Sophie Booth
, et al.
·
ERJ Open Research
Detection and Management of Eosinophilia in Asthmatic Adults and Children Receiving Dupilumab Treatment: A Focused Review
2026
·
Marco Caminati
, Francesca Cefaloni
, et al.
·
Journal of Inflammation Research
PDF
Show more works
View as search
Works count:
41
Citation count:
118
H-index:
5
I10-index:
3
Year
Topic
Type